Abstract
Gaucher disease (GD) is an autosomal recessive disorder resulting from glucocerebrosidase (GC) deficiency due to mutations in the gene (GBA) coding for this enzyme. We have developed a strategy for analyzing the entire GBA coding region and applied this strategy to 48 unrelated Brazilian patients with GD. We used long-range PCR, genotyping based on the Taqman® assay, nested PCR, and direct DNA sequencing to define changes in the gene. We report here seven novel mutations that are likely to be harmful: S125N (c.491G>A), F213L (c.756T>G), P245T (c.850C>A), W378C (c.1251G>C), D399H (c.1312G>C), 982-983insTGC (c.980_982dupTGC), and IVS10+1G>T (c.1505+1G>T). The last alteration was found as a complex allele together with a L461P mutation. We also identified 24 different mutations previously reported by others. G377S was the third most frequent mutation among the patients included in this study, after N370S and L444P. Therefore, this mutation needs be included in preliminary screens of Brazilian GD patients. The identification of mutant GBA alleles is crucial for increasing knowledge of the GBA mutation spectrum and for better understanding of the molecular basis of GD.
Competing interests: None declared
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alfonso P, Cenarro A, Perez-Calvo JI et al (2001) Mutation prevalence among 51 unrelated Spanish patients with Gaucher disease: identification of 11 novel mutations. Blood Cells Mol Dis 27:882–891
Alfonso P, Aznarez S, Giralt M et al (2007) Mutation analysis and genotype/phenotype relationships of Gaucher disease patients in Spain. J Hum Genet 52:391–396
Amaral O, Pinto E, Fortuna M et al (1996) Type 1 Gaucher disease: identification of N396T and prevalence of glucocerebrosidase mutations in the Portuguese. Hum Mutat 8:280–281
Amaral O, Marcao A, Sa Miranda M et al (2000) Gaucher disease: expression and characterization of mild and severe acid beta-glucosidase mutations in Portuguese type 1 patients. Eur J Hum Genet 8:95–102
Beutler E, Grabowski GA (2001) Gaucher disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3635–3668
Beutler E, Gelbart T, Scott CR (2005) Hematologically important mutations: Gaucher disease. Blood Cells Mol Dis 35:355–364
den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7–12
Grabowski GA, Horowitz M (1997) Gaucher's disease: molecular, genetic and enzymological aspects. Baillieres Clin Haematol 10:635–656
Horowitz M, Wilder S, Horowitz Z et al (1989) The human glucocerebrosidase gene and pseudogene: structure and evolution. Genomics 4:87–96
Hruska KS, LaMarca ME, Scott CR et al (2008) Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 29:567–583
Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073–1082
Lesage S, Anheim M, Condroyer C et al (2011) Large-scale screening of the Gaucher’s disease-related glucocerebrosidase gene in Europeans with Parkinson´s disease. Hum Mol Genet 20:202–210
Michelin K, Wajner A, de Souza FT et al (2005) Application of a comprehensive protocol for the identification of Gaucher disease in Brazil. Am J Med Genet 136:58–62
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Ramensky V, Bork P, Sunyaev S (2002) Human non-synonymous SNPs: server and survey. Nucleic Acids Res 30:3894–3900
Rozenberg R, Araujo FT, Fox DC et al (2006) High frequency of mutation G377S in Brazilian type 3 Gaucher disease patients. Braz J Med Biol Res 39:1171–1179
Sidransky E (2004) Gaucher disease: complexity in a “simple” disorder. Mol Genet Metab 83:6–15
Sobreira E, Pires RF, Cizmarik M, Grabowski GA (2007) Phenotypic and genotypic heterogeneity in Gaucher disease type 1: a comparison between Brazil and the rest of the world. Mol Genet Metab 90:81–86
Winfield SL, Tayebi N, Martin BM et al (1997) Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease. Genome Res 7:1020–1026
Yue P, Moult J (2006) Identification and analysis of deleterious human SNPs. J Mol Biol 356:1263–1274
Acknowledgments
The authors are grateful to the patients and their families who kindly agreed to participate in this study. We also thank the physicians who referred patients to our laboratory and provided clinical information. The authors would also like to thank Thais Santa Rita for her laboratory technical assistance in this work. MS, JCC, RG, and MLSP were supported by CNPq, Brazil. HB was supported by CAPES, Brazil. The work was also supported by Brazilian Funding Agencies (CNPq, FAPERGS, and FIPE-HCPA) and by Genzyme do Brazil.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Gregory M. Pastores
Synopsis
Synopsis
Novel and rare mutations in the GBA gene of patients with Gaucher disease.
Rights and permissions
Copyright information
© 2012 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Siebert, M., Bock, H., Michelin-Tirelli, K., Coelho, J.C., Giugliani, R., Saraiva-Pereira, M.L. (2012). Novel Mutations in the Glucocerebrosidase Gene of Brazilian Patients with Gaucher Disease. In: Zschocke, J., Gibson, K.M., Brown, G., Morava, E., Peters, V. (eds) JIMD Reports – Case and Research Reports, 2012/6. JIMD Reports, vol 9. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2012_174
Download citation
DOI: https://doi.org/10.1007/8904_2012_174
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-35517-2
Online ISBN: 978-3-642-35518-9
eBook Packages: MedicineMedicine (R0)